UiPath/$PATH
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About UiPath
UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform. The platform leverages a range of automation technologies, including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries, including claims processing, employee onboarding, invoice-to-cash, loan applications, and customer service. The company works in the Americas, Europe, the Middle East, and Africa, and Asia-Pacific, with the maximum revenue from the America.
- Ticker
- $PATH
- Sector
- Software & Cloud Services
- Primary listing
- NYSE
- Employees
- 3,981
- Headquarters
- New York, United States
- Website
- www.uipath.com
UiPath Metrics
BasicAdvanced
$7.2B
20.30
$0.68
1.02
-
Price and volume
Market cap
$7.2B
Beta
1.02
52-week high
$19.84
52-week low
$9.20
Average daily volume
32M
Financial strength
Current ratio
2.387
Quick ratio
2.139
Long term debt to equity
0.036
Total debt to equity
0.036
Profitability
EBITDA (TTM)
184.617
Gross margin (TTM)
82.58%
Net profit margin (TTM)
21.03%
Operating margin (TTM)
9.38%
Effective tax rate (TTM)
-71.64%
Revenue per employee (TTM)
$430,000
Management effectiveness
Return on assets (TTM)
3.67%
Return on equity (TTM)
20.03%
Valuation
Price to earnings (TTM)
20.301
Price to revenue (TTM)
4.211
Price to book
3.67
Price to tangible book (TTM)
4.28
Price to free cash flow (TTM)
19.966
Free cash flow yield (TTM)
5.01%
Free cash flow per share (TTM)
0.688
Growth
Revenue change (TTM)
14.98%
Earnings per share change (TTM)
1,732.84%
3-year revenue growth (CAGR)
14.44%
3-year earnings per share growth (CAGR)
28.41%
What the Analysts think about UiPath
Analyst ratings (Buy, Hold, Sell) for UiPath stock.
Analyst projections of the future price of UiPath stock.
Bulls say / Bears say
Revenue rose 13% to $410 million and ARR grew 12% in Q2 FY27, while UiPath recorded $32 million of GAAP operating income. That shows it is still growing while delivering operating profit. (UiPath)
Customers with at least $1 million of ARR grew 21% to 387, and dollar-based net retention improved to 109% from 108% a year earlier. These figures point to continued expansion among UiPath’s largest customers. (UiPath)
Management said 18 of its 20 recent large deals included broader platform and AI capabilities, and that such deals were running four to six times larger than historical averages. If that converts into sustained bookings, UiPath’s orchestration and AI products could lift contract values. (Investing.com)
UiPath did not give a preliminary FY28 ARR outlook at its September investor day; UBS said this was consistent with roughly 10% ARR growth and cut its price target. Investors therefore have limited company guidance to judge whether the new products can accelerate growth. (Yahoo Finance, Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 29 Oct 2026.
UiPath Financial Performance
Revenues and expenses
UiPath Earnings Performance
Company profitability
Upcoming events
No upcoming events
UiPath News
AllArticlesVideos
UiPath Recognized as a Leader in the 2026 Gartner® Magic Quadrant™ for Agentic Software Quality Assurance Platforms
Business Wire3 weeks ago
UiPath Recognized as a Leader in Analyst Evaluation for Adaptive Process Orchestration Software
Business Wire3 weeks ago
Why UiPath Stock Is Heading for Its Worst Month in 4 Years
Barrons1 month ago
Funds containing UiPath
AllUSDEURGBP
Fund name | Fund size | $PATH weighting |
|---|---|---|
Global X Artificial Intelligence£AIQG | $88M | 0.39% |
Global X Artificial Intelligence$AIQU | $88M | 0.39% |
iShares Automation & Robotics£RBTX | $4.9B | 0.28% |
iShares Automation & Robotics$RBOT | $4.9B | 0.28% |
iShares Automation & Robotics€2B76 | $5.3B | 0.28% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.